Drawing for BIFIBABY

USPTO serial 79063004

BIFIBABY

Reviewed by CopyMark Law Group

Reg. 3722572Status 709
Filing date
Status date
Registration date
Dec 8, 2009
Examiner
HABEEB, MYRIAH A
Law office
—

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BIFIBABY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

JOHN P. MURTAUGH

JOHN P. MURTAUGH PEARNE & GORDON LLP1801 EAST 9TH STREET, SUITE 1200CLEVELAND, OH 44114-3108UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001[ Fermentation extracts and bacteria for use in food manufacture, namely, micro-organisms and cultures of micro-organisms, in particular bacteria, bifid bacteria, yeast and fermented milk products, fermentation extracts and bacteria for use in food manufacture, namely, micro-organisms and cultures of micro-organisms, in particular probiotic lactic bacteria, probiotic bifid bacteria to be administered to human beings and reared animal species, not for medical or veterinary use, fermentation extracts and bacteria for use in food manufacture, namely, micro-organisms and concentrated cultures of probiotic micro-organisms in liquid, solid, dried and freeze-dried form ]SECTION 71 - CANCELLED—
005Bacterial and bacteriological preparations for medical or veterinary purposes, namely, micro-organisms and cultures of micro-organisms, in particular probiotic lactic bacteria, probiotic bifid bacteria to be administered to human beings and reared animal species, bacterial and bacteriological preparations for medical or veterinary purposes, namely, micro-organisms and cultures of micro-organisms, in particular probiotic lactic bacteria, probiotic bifid bacteria which * anallergic probiotic bifid bacteria which has beneficial activity on the intestinal microflora of babies * [ cause a metabolic effect that may affect cholesterols levels in the blood ], proprietary medicine containing micro-organisms and cultures of micro-organisms, in particular probiotic lactic bacteria, probiotic bifid bacteria for treating the intestinal bacterial flora, for restoring the balance of the intestinal bacterial flora when changed in the course of treatment with antibiotics or chemotherapy, for treating acute and chronic gastro-intestinal diseases caused by a change in the intestinal bacterial flora, for treating intestinal dismicrobic syndromes, namely, diseases linked to changes in the bacterial flora, namely, diarrhea, gastroenteritis, non-specific enteritis, colitis, ulcerous colitis and Crohn's disease, to be taken orally, in particular in the [ pharmaceutical ] form of capsules, tablets, solutions, suspensions, granules and granules in dried or freeze-dried form, food supplements, food supplements for medical use containing micro-organisms or cultures of micro-organisms, in particular probiotic lactic bacteria, probiotic bifid bacteria to be administered to human beings, dietary supplements, food supplements containing micro-organisms and cultures of micro-organisms, in particular probiotic lactic bacteria, probiotic bifid bacteria to be administered to human beings and reared animal species, not for medical or veterinary use, symbiotic supplements, namely, dietary supplements, containing micro-organisms or cultures of micro-organisms, in particular probiotic lactic bacteria, probiotic bifid bacteria and prebiotic fibres, food supplements for animals, not for medical useSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 9, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 8, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 14, 2022INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Dec 17, 2021INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Dec 17, 2021INPCINVALIDATION PROCESSED—
Oct 26, 2021INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 26, 2021C71TCANCELLED SECTION 71—
Dec 8, 2018REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Oct 11, 2018RNWLINTERNATIONAL REGISTRATION RENEWED—
Jul 7, 2017INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
May 10, 2017INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
May 10, 2017INPCINVALIDATION PROCESSED—
May 9, 2017INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Feb 17, 2017ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Sep 9, 2016NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Sep 9, 201671.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Aug 29, 2016EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Jul 13, 2016PR71POST REGISTRATION ACTION MAILED - SEC.71—
Jul 11, 2016APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jun 3, 2016ES71TEAS SECTION 71 RECEIVED—
Feb 26, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 27, 2014NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jan 29, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 25, 2011NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 24, 2010FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 24, 2010FIMPFINAL DISPOSITION PROCESSED—
Mar 8, 2010FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Feb 25, 2010CORRCORRECTION FROM IB ENTERED - NO REVIEW REQUIRED—
Feb 24, 2010COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Feb 24, 2010PLGLASSIGNED TO PARALEGAL—
Dec 8, 2009R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 30, 2009CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Sep 22, 2009PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 2, 2009NPUBNOTICE OF PUBLICATION—
Aug 20, 2009PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 19, 2009CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 29, 2009TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 29, 2009CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 29, 2009ALIEASSIGNED TO LIE—
Jul 13, 2009TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 10, 2009ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 10, 2009REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 10, 2009TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 6, 2009RFNTREFUSAL PROCESSED BY IB—
Jan 13, 2009RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 13, 2009RFRRREFUSAL PROCESSED BY MPU—
Jan 13, 2009RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 13, 2009MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 12, 2009CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 7, 2009DOCKASSIGNED TO EXAMINER—
Jan 7, 2009NWAPNEW APPLICATION ENTERED—
Jan 6, 2009REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance